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with impairment of microcirculatory blood flow in
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Background: Microcirculatory driving pressure is defined as the difference between post-arteriolar and venular
pressure. In previous research, an absence of correlation between mean arterial blood pressure (MAP) and
microcirculatory perfusion has been observed. However, the microcirculation may be considered as a low pressure
compartment with capillary pressure closer to venous than to arterial pressure. From this perspective, it is
conceivable that central venous pressure (CVP) plays a more important role in determination of capillary perfusion.
We aimed to explore associations between CVP and microcirculatory perfusion.
Methods: We performed a post-hoc analysis of a prospective study in septic patients who were resuscitated
according a strict non-CVP guided treatment protocol. Simultaneous measurements of hemodynamics and
sublingual Sidestream Dark Field imaging were obtained 0 and 30 minutes after fulfillment of resuscitation goals.
Data were examined for differences in microcirculatory variables for CVP ≤ or > 12 mmHg and its evolution over
time, as well as for predictors of a microvascular flow index (MFI) < 2.6.
Results: In 70 patients with a mean APACHE II score of 21, 140 simultaneous measurements of CVP and sublingual
microcirculation (vessels < 20 µmeter) were obtained. (MFI) and the percentage of perfused small vessels (PPV)
were significantly lower in the ‘high’ CVP (> 12 mmHg) group as compared to patients in the ‘low’ CVP
(≤12 mmHg) group (1.4 ± 0.9 vs. 1.9 ± 0.9, P = 0.006; and 88 ± 21% vs. 95 ± 8%, P = 0.006 respectively). Perfusion
pressure (MAP–CVP) and cardiac output did not differ significantly between both CVP groups. From time point 0 to
30 minutes, a significant increase in MFI (from 1.6 ± 0.6 to 1.8 ± 0.9, P = 0.027) but not in PPV, was observed, while
CVP and perfusion pressure significantly decreased in the same period. In a multivariate model CVP > 12 mmHg
was the only significant predictor for a capillary MFI < 2.6 (Odds ratio 2.5 (95% confidence interval 1.1-5.8),
P = 0.026).
Conclusion: We observed a significant association between a higher CVP and impairment of microcirculatory blood
flow. Further research is needed to elaborate on our hypothesis generating findings that an elevated CVP may act
as an outflow obstruction of organ perfusion.
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Resuscitation of critically ill patients is based on the gener-
ally accepted paradigm that cardiovascular optimization is
needed to ensure adequate oxygen delivery to the tissue.
However, whether corrections of systemic hemodynamics
are translated into improvement of oxygen delivery at the
capillary level often remains unclear in the clinical setting.
Indeed, the common finding in studies using microcircula-
tory monitoring is the absence of a clear association be-
tween microcirculatory and macrohemodynamic variables,
especially in conditions of sepsis [1]. This appears to be
clinically relevant: persisting sublingual microcirculatory
alterations after macrohemodynamic optimization are
known to be associated with adverse outcome [2]. At-
tempts to improve microcirculatory perfusion by increas-
ing mean arterial pressure (MAP) has shown to be
beneficial in some patients, whereas in some patients no
effect or a worsening of microvascular perfusion has been
observed [3-6]. The absence of a clear association between
microcirculation and macrocirculation may in part be
explained by the clinical setting. Since clinicians are trained
to keep systemic hemodynamic variables within a certain
range, extreme values are less likely to be present in clinical
datasets and might therefore cloud the presence of
associations between the two vascular compartments. An
alternative explanation may be hidden in fundamental
physiological theory. Maintenance of arterial blood pres-
sure within the range of autoregulation is generally ac-
cepted as the main prerequisite for organ perfusion. In this
paradigm the central venous pressure (CVP) is only rele-
vant as a relatively small determinant in the net driving
pressure, defined as MAP minus CVP. However, from the
perspective of the microcirculation, the steep part of the
pressure drop occurs upstream at the level of small arteri-
oles (resistance vessels). The microcirculation itself may be
considered as a very low pressure compartment. Therefore,
mean capillary pressure is much closer to venous than to
arterial pressure. From this perspective, CVP now becomes
a major determinant of capillary blood flow. Because
microcirculatory driving pressure is the net result of post
arteriolar minus venular pressure, one might postulate that
even a relatively mild increase in CVP may considerably in-
fluence the capillary perfusion pressure [3,7,8]. This issue
invites a study in search of a possible association between
raised CVP and microcirculatory flow. To this end we
analyzed combined data of Sidestream Dark Field (SDF)
in-vivo microscopy and CVP in septic patients. We
hypothesized there would be impairment of microvascular
blood flow under conditions of elevated CVP.
Methods
Patients and protocol
This study is a post-hoc analysis of a single center pro-
spective study of the microcirculation in patients ≥18 years of age with confirmed sepsis, included within
4 hours of intensive care unit (ICU) admission [9]. Pa-
tients were resuscitated according a strict non-CVP
guided treatment protocol aiming for the following re-
suscitation goals: a MAP of ≥ 60 mmHg, a mixed venous
oxygen saturation (SvO2) of ≥ 70% and a cardiac index
(CI) ≥ 2.5 L/min/m2. Systemic hemodynamic assessment
was achieved through continuous invasive monitoring of
arterial blood pressure and continuous cardiac output
and SvO2 measurements using a pulmonary artery
catheter (Vigilance, Edwards Lifesciences, Saint-Prex,
Switzerland). Stepwise goal-directed protocolized resus-
citation consisted of 1) repeated infusions of at least
250 mL of crystalloids, colloids, or blood products, until
the increase in left ventricular stroke volume was < 10%.
An upper limit of pulmonary artery wedge pressure of
18 mmHg was used as an extra precaution to avoid fluid
overload.; 2) treatment of inadequate systemic oxygen
supply (defined as CI < 2.5 L/min/m2 or SvO2 < 70%)
with dopamine administered at up to 10 μg/kg per mi-
nute and additional enoximone in case of an inadequate
response to dopamine; and 3) treatment with norepineph-
rine in case of MAP < 60 mmHg despite the aforemen-
tioned steps. For this post-hoc analysis, macro- and
microhemodynamic data obtained directly after fulfillment
of resuscitation endpoints (T0) as well as 30 minutes
thereafter (T30) were analyzed. During the study period,
therapeutic goals and resuscitation protocol remained un-
changed. The study was approved by the local ethics com-
mittee (Medical Research Ethics Committee, Medical
Center Leeuwarden, the Netherlands). Written informed
consent was obtained from all included patients or their
legal representative in accordance with local legislation.
SDF imaging and analysis
A SDF camera (MicroScan, MicroVision Medical,
Amsterdam, the Netherlands) is a form of handheld in-
travital microscopy enabling direct visualization of the
microcirculation [10]. In short, the SDF camera emits
stroboscopic green light with a wavelength (530 nm)
within the absorption spectrum of hemoglobin, thereby
depicting erythrocytes as black cells on the screen. The
area of visualization is 1 mm2. Offline software-assisted
analysis (AVA 3.0, MicroVision Medical, Amsterdam,
the Netherlands) yields information on both red blood
cell velocity (convective oxygen transport) and capillary
density (diffusion distance): the semi-quantitative micro-
vascular flow index (MFI), ranging from 0 (no flow) to 3
(continuous flow), and percentage of perfused vessels
(PPV) provide information on convexity, whereas total
vessel density (TVD) and perfused vessel density (PVD)
provide information on diffusion [11]. SDF imaging as
well as subsequent image analysis were performed in line
with international consensus [12,13].
Table 1 Baseline patient characteristics
Patients, baseline (n = 70 patients)
Age (years) 62 ± 16
Male 43 (61)
APACHE II 21 ± 6.5
SOFA 10 ± 3
Mechanical ventilation 69 (99)
Sepsis source
Lung 24 (34)
Abdomen 31 (44)
Urinary tract 4 (6)
Other 11 (16)
Mean ± SD or n (%).
Vellinga et al. BMC Anesthesiology 2013, 13:17 Page 3 of 7
http://www.biomedcentral.com/1471-2253/13/17Data collection and statistical analysis
Data on SDF imaging, hemodynamic variables, inotrope
dose and lactate, collected at 0 (T0) and 30 minutes (T30)
after fulfillment of resuscitation goals, were analyzed to
examine the relationship between CVP and sublingual
microcirculation. Microcirculatory variables were re-
stricted to small vessels (< 20 μm) only. Statistical analysis
was performed using SPSS 18 (IBM, New York, USA). Dif-
ferences in microcirculation and macrocirculation were
evaluated for two CVP groups: CVP ≤ 12 mmHg (low
CVP) and CVP > 12 mmHg (high CVP). This cut-off
value is the lower limit of the advised CVP goal (12–
15 mmHg) for the resuscitation of mechanically ventilated
septic patients according to the Surviving Sepsis Cam-
paign (SSC) guidelines [14]. Furthermore, perfusion pres-
sure, defined as MAP minus CVP, was calculated for each
group and each time point. Backwards stepwise logistic re-
gression was employed to detect determinants of a capil-
lary MFI < 2.6. This threshold is the lower limit of the
95% confidence interval for healthy subjects [15]. In a re-
cent study, this cut-off value was confirmed for the re-
sponse of the microcirculation during fluid therapy,
underlining the clinical significance of this threshold [16].
Predictors in univariate logistic regression with P < 0.25
for a capillary MFI were included for subsequent model-
ing. Tested predictors were perfusion pressure, lactate
level, norepinephrine and dopamine dose, PEEP, cardiac
index, SvO2, CVP as a continuous variable, CVP >
12 mmHg and MAP.
Evolution over time (i.e. between T0 and T30) was also
evaluated for both microcirculation and macrocirculation.
The Kolmogorov-Smirnov test was used to test
whether data were distributed normally; a Student’s T-
test was used to test for differences between groups.
Data are presented as mean ± standard deviation unless
specified otherwise. A P <0.05 was considered statisti-
cally significant.
Results
Seventy patients with an APACHE II score of 21 ± 6.5
were included; ICU mortality was 21%. Table 1 presents
a summary of baseline characteristics.
Static measurements
Out of the 140 combined measurements of CVP and
microcirculation in the first hour of completed resuscita-
tion, 80 measurements (57%) were obtained in patients
with a CVP ≤ 12 mmHg. CVP in the ‘high’ CVP group
(CVP > 12 mmHg) was significantly higher in compari-
son to the low CVP group (16.6 ± 2.4 vs. 9.0 ± 2.8 mmHg,
P =0.000). MFI and PPV were significantly lower in pa-
tients with a ‘high’ CVP (1.44 ± 0.94 vs. 1.89 ±0.91, P =
0.006; and 88 ± 21 vs. 95 ± 8%, P = 0.006) (Figure 1). In
the ‘low’ CVP group, 66% of patients had a capillary MFI< 2.6, whereas 83% of patients with a CVP > 12 mmHg
had a MFI < 2.6 mmHg (P = 0.023). PVD and TVD did
not differ significantly between both CVP groups. At the
macrohemodynamic level, both CI, MAP and perfusion
pressure did not differ significantly between groups.
However, SvO2 was significantly higher in patients in the
‘low’ CVP group, and lactate levels significantly lower. A
non-significant difference in perfusion pressure was ob-
served (Table 2). In a multivariate logistic regression
analysis, the only significant predictor for an abnormal
MFI was a CVP > 12 mmHg (Odds ratio 2.5 (95% confi-
dence interval 1.1-5.8), P = 0.026).
Dynamic measurements
Table 3 provides details on changes over time in
macrohemodynamic and microcirculatory variables be-
tween T0 and T30. MFI was significantly higher at T30 as
compared to T0 values (1.58 ± 1.62 vs. 1.81 ± 0.92, P =
0.027). This was accompanied by a significant decrease in
CVP, MAP and perfusion pressure between T0 and T30.
No significant change in cardiac index was observed.
Discussion
Our results show an association between elevated CVP
and impairment of microcirculatory blood flow in the
early phase of human sepsis. At the same time, MAP
and perfusion pressure did not differ significantly be-
tween both CVP groups. Moreover, in the short time
frame of our analysis, we observed a significant rise in
MFI in combination with a reduction in CVP, despite a
decrease in MAP and perfusion pressure. These observa-
tions are compatible with our hypothesis that the ‘clas-
sical’ perfusion pressure, defined as MAP minus CVP,
may not reflect the true driving pressure over the micro-
circulation. In this respect, two factors should be taken
into consideration: 1) inflow pressure of the microcircu-
lation may significantly differ from MAP as a result of
post-arteriolar pressure drop and 2) the microcirculation
Figure 1 Boxplots of microvascular flow index (MFI) in patients with a central venous pressure (CVP) ≤ or > 12 mmHg. *For differences
in MFI between CVP groups. A P < 0.05 was considered statistically significant.
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hydrostatic pressures slightly above CVP. However, dif-
fusion distance seems to be unaffected, as reflected by
the absence of a significant difference in TVD and PVD
between CVP groups as well as over time. This may be
explained by the fact that upregulation of the number of
perfused capillaries, to compensate for a reduction in
convective oxygen transport, may occur outside the
timeframe of our observations [17].Table 2 Haemodynamic variables and microcirculatory param
All (n = 140) CVP
MAP (mmHg) 70 ± 13
Cardiac index (l/min/m2) 4.2 ± 1.3
CVP (mmHg) 12.3 ± 4.6
Perfusion pressure (mmHg) 57 ± 13
PEEP (cm H2O) 13 ± 3
SvO2 (%) 71 ± 7.9
Lactate (mmol/L) 2.6 ± 2.2
Dopamine (n,%, μg/kg/min) 121, 86, 6.7 ± 3.1
Norepinephrine (n,%, μg/kg/min) 68, 49, 0.14 ± 0.15 3
MFI (AU) 1.70 ± 0.95
PPV (%) 92 ± 15
TVD (mm/mm2) 14.18 ± 2.11
PVD (mm/mm2) 13.70 ± 7.88
Mean ± SD unless specified otherwise. CVP = Central venous pressure. MAP = mean
oxygen saturation. MFI = microvascular flow index. AU = arbitrary units. TVD = tota
density. TVD, MFI, PPV and PVD for small vessels, i.e. < 20 μmeter. *P < 0.05 is cons
difference in dose between CVP groups.Data on the effect of elevated venous pressure on
microcirculatory blood flow are limited: SDF imaging of
renal blood flow in pigs showed a decrease in renal MFI
in intra-abdominal hypertension, which is a model for
venous outflow obstruction [18]. In an experimental
setting, aiming for a CVP < 10 mmHg by intravenous
administration of nitroglycerin in gastric tube recon-
struction in pigs resulted in a higher microvascular
blood flow as measured by laser Doppler flowmetry ineters for all measurements as well as per CVP group
≤12 mmHg (n = 80) CVP >12 mmHg (n = 60) P a
68 ± 12 75 ± 13 0.443
4.3 ± 1.1 4.0 ± 1.5 0.121
9.0 ± 2.8 16.6 ± 2.4 0.000*
55 ± 13 59 ± 12 0.055
13 ± 3 14 ± 3 0.053
72 ± 7.0 68 ± 8.5 0.003*
1.8 ± 1.4 3.6 ± 2.6 0.000*
66, 83, 5.9 ± 2.7 55, 92, 7.9 ± 3.1 0.000*,b
2, 40, 0.10 ± 0.06 36, 60, 0.18 ± 0.19 0.013*,b
1.89 ± 0.91 1.44 ± 0.94 0.006*
95 ± 8 88 ± 21 0.006*
14.31 ± 1.95 14.00 ± 2.31 0.410
14.66 ± 9.81 12.42 ± 3.8 0.066
arterial pressure. Perfusion pressure = MAP minus CVP. SvO2 = mixed venous
l vessel density. PPV = percentage of perfused vessels. PVD = perfused vessel
idered statistically significant. a For differences between CVP-groups. bfor
Table 3 Haemodynamic variables and microcirculatory parameters for T0 and T30
T = 0 (n = 70 patients) T = 30 (n = 70 patients) P a
MAP (mmHg) 71 ± 12 68 ± 13 0.008*
Cardiac index (l/min/m2) 4.2 ± 1.3 4.1 ± 1.3 0.291
CVP (mmHg) 12.6 ± 4.8 11.9 ± 4.3 0.017*
Perfusion pressure (mmHg) 59 ± 13 56 ± 13 0.034*
PEEP (cm H2O) 13 ± 3 13 ± 3 0.425
SvO2 (%) 71 ± 7.4 70 ± 8.4 0.141
Lactate (mmol/L) 2.6 ± 2.2 2.6 ± 2.3 0.779
Dopamine (n,%, μg/kg/min) 60, 86, 5.8 ± 3.7 61, 87, 5.9 ± 3.7 0.772
Norepinephrine (n,%, μg/kg/min) 33, 47, 0.07 ± 0.11 35, 50, 0.07 ± 0.15 0.401
MFI (AU) 1.58 ± 1.62 1.81 ± 0.92 0.027*
PPV (%) 91 ± 18 94 ± 12 0.197
TVD (mm/mm2) 14.27 ± 2.22 14.08 ± 2.01 0.415
PVD (mm/mm2) 14.11 ± 10.84 13.28 ± 2.71 0.496
Mean ± SD unless specified otherwise. T0: directly after fulfillment of resuscitation endpoints. T30: 30 minutes after T0. CVP = Central venous pressure. MAP =
mean arterial pressure. Perfusion pressure = MAP minus CVP. PEEP = positive end-expiratory pressure. SvO2 = mixed venous oxygen saturation. MFI = microvascular
flow index. AU = arbitrary units. TVD = total vessel density. PPV = percentage of perfused vessels. PVD = perfused vessel density. TVD, MFI, PPV and PVD for small
vessels, i.e. < 20 meter. aFor differences between T0 and T30. *P < 0.05 is considered statistically significant.
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creases in MAP [19]. The same group reported an in-
crease in microvascular blood flow after topical
administration of nitroglycerin in gastric tube recon-
struction in humans, being compatible with the hy-
pothesis that venous outflow obstruction results in
impairment of microvascular flow [20]. Several studies
report impairment of microvascular perfusion in small
increases in venous pressure by venous congestion
plethysmography in humans [21,22].
It is conceivable that raising CVP under specific cir-
cumstances may be beneficial to tissue perfusion [16].
However, several studies point towards an ambiguous
role of CVP in resuscitation of critically ill patients. Not
only CVP failed as a useful measure for the assessment
of preload and fluid responsiveness [23], a CVP >
12 mmHg was also associated with a higher mortality in
this specific patient group in the early phase of resuscita-
tion [24]. Our data add to the understanding that taking
elevated CVP levels as a general endpoint will not auto-
matically result in improved organ perfusion. Therefore,
it is conceivable that CVP guided resuscitation as advo-
cated by for instance Surviving Sepsis Campaign (SSC)
guidelines might have an undesirable effect on microcir-
culatory perfusion [14].
Our study has several limitations. Due to the post hoc
design of the study, we were limited in the ability to ex-
plore the complex relationship between venous pressure
and microcirculatory blood flow. Therefore, it is of ut-
most importance to stress that our finding is merely hy-
pothesis generating. Imbalances between the two CVP
groups in inotrope use, lactate levels and SvO2 may both
be explained as confounders, exaggerating the observeddifferences in microcirculatory perfusion. Extravascular
pressures such as intra-abdominal pressure and positive
end expiratory pressure (PEEP) settings may also have
influenced CVP. PEEP level did not differ significantly be-
tween groups, nor did it change over time. In this study,
data on intra-abdominal pressure are lacking. However,
correction for these potential confounders in multivariate
analysis did not eliminate the observed differences in
microvascular perfusion between CVP groups. Moreover,
the potential confounding factors may also serve as add-
itional markers of impaired organ perfusion, underlining
the importance of the observed differences between the
groups.
SDF imaging of the sublingual microcirculation was
performed, but venous pressure was not measured at
this level. It is imaginable that venous pressure in the su-
perior vena cava is not representative for venous pres-
sure at the sublingual site and that this might have
influenced the association between venous pressure and
the sublingual microcirculation.
We are also aware of the fact that microcirculatory
blood flow is determined by other factors than inflow and
outflow pressures alone. Not only may there be a further
pressure drop within the capillary and venular compart-
ment, it is also of note that microcirculatory flow regula-
tion is not a static process. In reality, vasomotion is the
constant opening and closing of capillaries under influence
of downstream hypoxic signals [25]. However, in the clin-
ical setting, this complexity of microcirculatory flow is a
complete black box. In previous papers, authors have tried
to establish a clear relationship between the input signal
(i.e. arterial pressure) and the microcirculation and were
unable to do so [1].
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early course of sepsis resuscitation. Therefore, extrapola-
tion of our findings to a larger time window is difficult.
It was decided to limit the evaluation of SDF and CVP
data to the measurements obtained at 0 and 30 minutes,
because we observed a tendency towards progression of
MFI towards 3 in the majority of patients during the
24 hour study period in the original data set [9]. Due to
this regression to the mean phenomenon, it was
expected that the a priori probability for detecting an as-
sociation between CVP and microcirculation was highest
in the early phase after initial sepsis resuscitation.
Conclusion
The observed association between elevated CVP and im-
pairment of microcirculatory perfusion is in line with
physiological theory that microcirculatory perfusion
pressure is predominantly determined by CVP as an out-
flow obstruction. This may have especially potential con-
sequences for the use of a elevated CVP levels as a
resuscitation endpoint. Clearly, our study was intended
merely to explore the possibility of an association be-
tween microcirculatory parameters and elevated CVP in
sepsis. The study design does not allow for making as-
sumptions regarding causality. Further research is
needed to clarify the role of elevated CVP in micro-
vascular dysfunction in sepsis.
Key messages
Microcirculatory perfusion pressure can be defined as
post-arteriolar pressure minus venular pressure and is
much closer to venous pressure as to arterial pressure.
An increased venous pressure is associated with im-
pairment of microcirculatory perfusion in patients with
severe sepsis and septic shock.
This observation needs to be elucidated further in
terms of a causal relationship, but could have potential
consequences for resuscitation guidelines that are based
on the assumption that elevated CVP will automatically
improve organ perfusion.
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